The National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, awarded a $15,656.00 firm-fixed-price purchase order to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The service contract is for the Sartorius Incucyte S3, a live-cell analysis system used to support the NCI's biomedical research and development initiatives, particularly in areas such as infectious diseases, cancer, and drug...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The $15,969.40 contract is for a service agreement to provide the NCI with the S3 IncuCyte live-cell analysis system, which supports cutting-edge biomedical research across infectious diseases, cancer studies, and translational sciences....
This is a $15,972.00 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Sartorius Corporation, a foreign-owned manufacturer of laboratory equipment and solutions. The contract is for a service agreement to provide the NCI with an IncuCyte S3 Live Cell Analysis System, which is a specialized biomedical instrument used for cutting-edge research in areas such as infectious diseases,...
This is a $21,394.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for the maintenance of an IncuCyte SX5 live cell imaging system used for real-time cell health and viability measurements to support biomedical research. The award has an ultimate completion date of April 30, 2026 and was not set aside for any specific business type....
Sartorius Corporation was awarded a firm fixed-price purchase order totaling $15,656 by the National Institutes of Health's National Cancer Institute to provide an IncuCyte S3 Live Cell Analysis System under a non-set aside contract. As a manufacturer of laboratory equipment and solutions for biopharmaceutical and life sciences research, Sartorius will deliver the biomedical imaging hardware, software, and associated services to support the National Cancer Institute's cell-based research and...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract is for the provision of an IncuCyte S3 live-cell analysis system and associated software and services from December 1, 2024 to November 30, 2025 at a ceiling value of $15,656.00. The contract was awarded on...
This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment. The $131,411.00 firm-fixed-price purchase order was for a Sartorius Incucyte S3 HD/2CLR live cell imaging system with accessories and service agreements. This sole-source award was made without full and open...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $12,248 purchase order to Sartorius Corporation for a service agreement and warranty for the IncuCyte S3 system. Under this firm fixed price contract, Sartorius Corporation Division will provide support and maintenance services for the IncuCyte S3 live-cell analysis instrumentation from November 2023 through April 2024 at its Rockville, Maryland location. No subcontractors or set...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Sartorius Corporation, a foreign-owned, for-profit manufacturer of laboratory equipment and solutions. The contract provides for the maintenance of an IncuCyte S3 Imaging System, a specialized live-cell analysis instrument, for a period of approximately 1 year from April 2024 to April 2025. The total ceiling value of the...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $14,544.60 firm fixed price purchase order to Sartorius Corporation for a SERVICE AGREEMENT OF INCUCYTE S3 SW/SVC. Sartorius Corporation, a division of Sartorius Aktiengesellschaft, will provide the requested products and services from their Rockville, Maryland location of performance over a one year period ending in July 2024. No set aside designation or major subcontractors were...
This federal contract awarded to Sartorius Corporation provides one (1) IncuCyte S3 live-cell analysis system for use by the National Cancer Institute's (NCI) Center for Cancer Research (CCR), Oncogenomic Section. The contract, valued at $125,052.76, is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH). The system will support ongoing cancer research at the CCR, including CRISPR-based genetic screens, drug screens, and adaptive cell-based therapeutics. This contract did not utilize a set-aside designation. Sartorius Corporation, a foreign-owned for-profit organization that manufactures laboratory equipment, is the prime contractor. No subcontractors were identified. Sartorius has provided similar biomedical equipment and services to various NIH institutes, the Food and Drug Administration, Centers for Disease Control and Prevention, and other federal agencies.